Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...